Partner and Registered Patent Attorney Morgan Xu, Ph.D. and Associate and Registered Patent Attorney Mi Cai, Ph.D. will speak at a Lunch & Learn session, “From Innovation to Valuation: An IP Playbook for Biotech Founders, Leaders & Investors” a the BioSpark 2026 Annual Conference.
Biotech IP isn't just legal paperwork — it's the engine behind business value. In this Lunch & Learn session, Foley Hoag attorneys Mi Cai, Ph.D., J.D. and Morgan Xu, Ph.D., J.D. guide biotech founders, leaders, and investors through the five critical stages of the biotech IP lifecycle: securing foundational IP early and affordably, building a smart patent filing strategy across the pipeline, establishing freedom-to-operate and clear ownership terms before partners come knocking, staying deal-ready with clean title and cross-border compliance, and ultimately positioning a well-documented portfolio to drive transaction value.
The core message is clear: business and science lead, and IP enables. Every IP decision should trace back to a business goal, and early discipline beats late cleanup — because fixing IP problems after a deal is on the table costs more and risks the deal itself. Whether you're spinning out of a university, building a pipeline, or preparing for an exit, being diligence-ready before you need to be is the best competitive advantage.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
